Chart calendar Protalix BioTherapeutics, Inc.

5b248ecb1cb676a9a88469352.mFXYnzDe0zz7rEmtEPWhEmggD0xHhbWIExqTXB3DL4o.7gC0-wm5nguq6zD_ep_Sc1BmfiQI1JjDKivZBkuQfcbQOojLUb-md6_7eQ~d85675e25f09936fd43e9cc1b60c6e94

Upcoming events on Protalix BioTherapeutics, Inc.

No events available

Past events on Protalix BioTherapeutics, Inc.

2026-08-12

Earnings presentation

08:00 am
2026-08-12

Earnings release - Q2 2026

2026-06-25

Annual General Meeting

08:00 am
2026-05-13

Earnings release - Q1 2026

2026-05-13

Earnings presentation

08:00 am
2026-03-18

Earnings release - Annual 2025

2026-03-18

Earnings presentation

08:00 am
2025-11-13

Earnings presentation

08:00 am
2025-11-13

Earnings release - Q3 2025

Annual results

Fiscal PeriodDecember 2023 2024 2025 2026 2027 2028
Net sales
Million USD
Released
Forecast
Spread
65,5
64,0
2.41%
53,4
53,9
-0.98%
52,7
58,0
-9.03%

82,2


66,5


68,8

EBITDA
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread
10,5
11,5
-9.12%
3,92
1,44
171.26%
-5,50
-0,83
-563.85%

22,6


2,59


1,13

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
8,57
9,56
-10.41%
4,15
1,62
156.18%
-5,61
-0,48
-1061.08%

23,4


4,08


1,71

Net income
Million USD
Released
Forecast
Spread
8,31
8,12
2.31%
2,93
1,22
140.03%
-6,60
-0,75
-775.28%

19,6


3,79


1,52

EPS
USD
Released
Forecast
Spread
0,09
0,11
-14.29%
0,04
0,02
166.67%
-0,08
-0,01
-1500%

0,24


0,05


0,02

Announcement Date14/03/2417/03/2518/03/26-

Quarterly results

Fiscal PeriodJune 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2026 Q1 2026 Q2 2026 Q3 2026 Q4 2027 Q1 2027 Q2 2027 Q3 2027 Q4
Net sales
Million USD
Released
Forecast
Spread
18,2
18,7
-2.81%
10,1
21,6
-53.18%
15,7
13,5
16.11%
17,9
17,9
-0.08%
9,12
14,4
-36.47%
33,8
11,5
194.3%
19,9
12,9
53.86%

12,4


16,1


15,5


17,5


18,8


20,9

EBIT
Million USD
Released
Forecast
Spread
7,21
4,74
52.22%



1,17
2,20
-46.65%
2,13
4,25
-49.87%
-4,66
0,01
-34603.7%
21,1
-1,42
1587.06%
4,67
-1,32
454.48%

-1,85


-1,38













Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
7,32
4,90
49.26%



0,66
2,53
-73.91%
2,24
4,60
-51.28%
-4,78
0,35
-1468.48%
21,1
-1,14
1951.23%
4,86
-1,02
576.24%

-1,53


-1,06













Net income
Million USD
Released
Forecast
Spread
6,49
4,90
32.49%



0,16
2,38
-93.1%
2,36
4,44
-47%
-5,50
0,21
-2702.36%
18,3
-1,01
1906.41%
3,78
-0,96
491.8%

-1,45


-1,01













EPS
USD
Released
Forecast
Spread
0,09
0,07
28.57%
-0,05
0,08
-162.5%
0,00
0,03
-
0,03
0,06
-45.45%
-0,07
0,01
-1500%
0,22
-0,01
2300%
0,05
-0,01
600%

-0,02


-0,02


0,01


0,01


0,03


0,06

Announcement Date17/03/2509/05/2514/08/2513/11/2518/03/2613/05/2612/08/26------
2026-10-25

Board of Directors Meeting

2026-10-25

Board of Directors Meeting

2026-10-25

Earnings release - Q2 2027

2026-10-26

Board of Directors Meeting

2026-10-26

Information meeting

10:00 am
2026-10-26

Earnings release - Q2 2027

2026-10-26

Earnings presentation

08:30 am
2026-10-26

Board of Directors Meeting

2026-10-26

Earnings presentation

03:00 am
2026-10-26

Board of Directors Meeting

Past sector events for Protalix BioTherapeutics, Inc.

2026-10-24

Earnings release - Q3 2026

2026-10-24

Earnings release - Q3 2026

2026-10-24

Earnings release - Q3 2026

2026-10-24

Earnings release - Q3 2026

2026-10-24

Earnings release - Q3 2026

2026-10-24

Earnings release - Q3 2026

2026-10-24

Earnings release - Q3 2026

2026-10-24

Earnings release - Q3 2026

2026-10-24

Earnings release - Q3 2026

2026-10-24

Earnings release - Q3 2026

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Protalix BioTherapeutics, Inc.

Net sales - Rate of surprise

Rate of surprise - Net sales - Annual - Protalix BioTherapeutics, Inc.

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Protalix BioTherapeutics, Inc.
  1. Stock Market
  2. Stocks
  3. PLX Stock
  4. Calendar Protalix BioTherapeutics, Inc.